北京招聘

Responsibilities:

1. Manage antibody discovery projects together with project leaders, track project progress, timeline, resources and budget, communicate and align with supporting function teams to move project forward. Assist and guide project team to plan the activities, resources and make Go/No Go decisions. Facilitate the transition from biologics discovery to preclinic/CMC and IND stages. Report to senior management team on project status and recommend project prioritization.  (50%)

2. Assist to develop research portfolio strategy, analyze immune-oncology, autoimmune/inflammation landscape, recommend and guide project proposal, prioritization and exit strategies (20%).

3. Coordinate external collaborative studies and projects, including outsourcing CRO work, Align internal and external project activities (20%)

4. Serve as scientific advisor for antibody oncology/immunology projects (10%)

 

 Requirements:

 1. Candidate should have a PhD degree in oncology, immunology, or relevant fields. 10 year industry experience is expected. Project management training is a plus

2. Track record of contributing to progression of antibody discovery programs from target validation to IND filing. Hands-on experience of consolidating non-clinical pharmacology, GLP tox, CMC data package for IND filing. Project management skills in the field of preclinical/CMC/research in biotech or pharmaceutical industry

3. Understanding the science of immunology or oncology drug discovery. Familiar with the process of biologics discovery, preclinic and CMC, particularly the timeline, milestones and resource management

4. Experience in project management, cross-function collaboration, CRO outsourcing management etc. Portfolio management experience is a strong plus

5. Excellent organizational and planning skills in order to meet deadlines and to handle multi tasks.

6. Experience in managing teams in a matrix environment

7. Strong aspiration for drug discovery work, diligent, self-motivated, independent, strong sense of responsibility

8. Strong communication skills in English

9. Good interpersonal skills for building relationships across functions internally and externally. Effective collaboration with colleagues and partners

  

和铂医药是一家专注于肿瘤免疫领域创新药物研究与开发的全球化运营生物医药公司。公司将运用其拥有的全部自主知识产权的全人源单抗的转基因鼠系列核心技术平台，建立下一代治疗性肿瘤抗体药物产品管线,并将围绕Harbour的两大平台拓展合作与授权业务。公司总部及研发基地位于中国上海，另外在美国马塞诸塞州剑桥设立商业运营中心，在荷兰鹿特丹设立抗体研发平台创新中心，在波士顿地区设立了创新中心包括实验室和研发团队，也将在江苏昆山设立研发基地。公司拥有资深管理团队以及丰富的药物研究与开发经验。和铂医药要为满足中国及全球病人的需求而不断努力，依托拥有自主知识产权的核心技术平台,创建一个在肿瘤治疗领域有科学与技术领导力的国际性生物医药公司。同时, 在药物研发领域建立以技术平台为基础的对外合作，整合新的技术，推动中国整个抗体研发产业的进步。

Company Overview
Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology and autoimmunity/inflammation. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery.
The company is building its proprietary pipeline internally, through collaborations with co-development partners, as well as through selective preclinical and clinical stage asset acquisitions. Harbour BioMed also licenses the platforms to companies and academic institutions through its Harbour Antibodies subsidiary.
Harbour BioMed has headquarters and an R&D site in Shanghai, business operations in Cambridge, MA, and antibody platform development in Rotterdam, The Netherlands.
The company has an innovation center including research lab and a development team in Boston. Also, we are expanding to Kunshan site in Jiangsu for our R&D operation.